Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Berger

Showing results (21-30 of 359) with videos related to

Pageof 36
Sort By:
Cancer Cytopathology|February 7, 2015
Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinomaRonak H Shah, Sasinya N Scott, A Rose Brannon, et al.
Journal of Cutaneous Pathology|March 18, 2014
Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratoticaJanet Y Li, Michael F Berger, Ashfaq Marghoob, et al.
Molecular Microbiology|August 7, 2008
The Vibrio harveyi master quorum-sensing regulator, LuxR, a TetR-type protein is both an activator and a repressor: DNA recognition and binding specificity at target promotersAudra J Pompeani, Joseph J Irgon, Michael F Berger, et al.
Cancer Research|January 17, 2009
Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cellsChristopher D Scharer, Colleen D McCabe, Mohamed Ali-Seyed, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2014
Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosisAndre L Moreira, Helen H Won, Robert McMillan, et al.
Nature Biotechnology|September 26, 2006
Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificitiesMichael F Berger, Anthony A Philippakis, Aaron M Qureshi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 25, 2023
Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell CarcinomaSnjezana Dogan, Bin Xu, Satshil Rana, et al.
Plos One|December 3, 2010
Notch and MAML-1 complexation do not detectably alter the DNA binding specificity of the transcription factor CSLCristina Del Bianco, Anastasia Vedenko, Sung Hee Choi, et al.
The American Journal of Surgical Pathology|June 16, 2015
NF1 Mutations Are Common in Desmoplastic MelanomaThomas Wiesner, Maija Kiuru, Sasinya N Scott, et al.
Nature Genetics|November 16, 2004
Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarraysSonali Mukherjee, Michael F Berger, Ghil Jona, et al.
Pageof 36

Showing results (21-30 of 359) with videos related to

Sort By:
Pageof 36
Cancer Cytopathology|February 7, 2015
Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinomaRonak H Shah, Sasinya N Scott, A Rose Brannon, et al.
Journal of Cutaneous Pathology|March 18, 2014
Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratoticaJanet Y Li, Michael F Berger, Ashfaq Marghoob, et al.
Molecular Microbiology|August 7, 2008
The Vibrio harveyi master quorum-sensing regulator, LuxR, a TetR-type protein is both an activator and a repressor: DNA recognition and binding specificity at target promotersAudra J Pompeani, Joseph J Irgon, Michael F Berger, et al.
Cancer Research|January 17, 2009
Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cellsChristopher D Scharer, Colleen D McCabe, Mohamed Ali-Seyed, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2014
Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosisAndre L Moreira, Helen H Won, Robert McMillan, et al.
Nature Biotechnology|September 26, 2006
Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificitiesMichael F Berger, Anthony A Philippakis, Aaron M Qureshi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 25, 2023
Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell CarcinomaSnjezana Dogan, Bin Xu, Satshil Rana, et al.
Plos One|December 3, 2010
Notch and MAML-1 complexation do not detectably alter the DNA binding specificity of the transcription factor CSLCristina Del Bianco, Anastasia Vedenko, Sung Hee Choi, et al.
The American Journal of Surgical Pathology|June 16, 2015
NF1 Mutations Are Common in Desmoplastic MelanomaThomas Wiesner, Maija Kiuru, Sasinya N Scott, et al.
Nature Genetics|November 16, 2004
Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarraysSonali Mukherjee, Michael F Berger, Ghil Jona, et al.
Pageof 36